ArticleNatural products and bioprospecting2026
Structural characterization and antiviral activity of polysaccharide from Codonopsis pilosula.
Article in Natural products and bioprospecting, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Codonopsis polysaccharides exhibit diverse biological activities, but their antiviral effects against the H1N1 influenza A virus and how these activities change after sulfation modification remains unclear. In this study, crude Codonopsis polysaccharide (COP) was obtained via water extraction and alcohol precipitation, and COP-1 (2.1 × 103 Da, β-D-(2 → 1)-fructan) was isolated and purified. Both COP and COP-1 were modified by sulfation using the sulfur trioxide-pyridine method, yielding derivatives SCOP and SCOP-1 with degrees of substitution of 1.792 and 1.403, respectively. Antiviral activity was evaluated in MDCK cells using MTT and TCID₅₀ assays, revealing that COP, SCOP, and SCOP-1 all inhibited H1N1 replication, with sulfation significantly enhancing antiviral activity. Time-of-addition experiments indicated that inhibition occurred during the early phase of infection (0-4 h). Annexin V-PI staining confirmed that these compounds reduced virus-induced early apoptosis. In H1N1-infected A549 cells, they suppressed NF-κB p65 phosphorylation and downregulated the expression of IL-6, IL-8, MCP-1, CCL-5, TNF-α, and TRAIL. Overall, Codonopsis polysaccharides and their sulfated derivatives exert anti-influenza effects through a triple mechanism involving inhibition of early viral replication, anti-apoptotic activity, and anti-inflammatory action, making them promising candidates for antiflu therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.